Two subjects had F4 hepatic fibrosis, two had F3 hepatic fibrosis, one had F2 hepatic fibrosis, and nine had F0F1 hepatic fibrosis
This letter in a narrow respect validates, at least anecdodately, the core argument firms like Novo Nordisk and Eli Lilly are making: that compounded versions of their drugs, produced outside a more robust CGMP framework, carry real and documented patient safety risks
Phospholipase C guanine nucleotide exchange factor activity and activation of Rap1
However, Semaglutides unique method of slowing digestion and regulating insulin gives it an edge for those looking to address both weight and metabolic health concerns
Key Takeaway: The goal of GLP-1 needle selection is to find the thinnest (highest gauge) and shortest needle possible that still successfully reaches the subcutaneous fat layer
These outcome trials aimed to determine cardiovascular safety and thus most of them were designed to show non-inferiority of the drug against placebo